Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Prevention of Recurrent Preterm Delivery by a Natural Progesterone Agent

This study has been withdrawn prior to enrollment.
(Study withdrawn for financial problems. We didnwt get a grant we needed for purchesing the medication for the study.)
Information provided by:
The Baruch Padeh Medical Center, Poriya Identifier:
First received: May 23, 2006
Last updated: June 26, 2008
Last verified: June 2007

To examine the preterm delivery rate of a preterm delivery high risk group of pregnant women, using once daily natural progesterone agent.

Condition Intervention
Premature Birth
Drug: Crinone Gel 8%

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label

Resource links provided by NLM:

Further study details as provided by The Baruch Padeh Medical Center, Poriya:


Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

Pregnancy 24 weeks' gestation Preterm labor in previous pregnancies


Exclusion Criteria:

  • No medications for PTL or any kind of progesterone.
  • Cervical suture
  • Multiple pregnancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00329316

Sponsors and Collaborators
The Baruch Padeh Medical Center, Poriya
Study Chair: Yuri Perlitz, MD The Baruch Padeh Medical Center, Poriya
Principal Investigator: Mosheh Ben Ami, Prof. Head of Obs/Gyn ,The Baruch Padeh Medical center, Poriya
  More Information

No publications provided Identifier: NCT00329316     History of Changes
Other Study ID Numbers: PTL Progesterone Perlitz.CTIL
Study First Received: May 23, 2006
Last Updated: June 26, 2008
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by The Baruch Padeh Medical Center, Poriya:
Pre-term labor
progesterone processed this record on March 01, 2015